Citigroup’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.67M | Buy |
|
|||||
|
2023
Q1 | $728K | Buy |
|
|||||
|
2022
Q4 | $256K | Sell |
|
|||||
|
2022
Q3 | $262K | Sell |
|
|||||
|
2022
Q2 | $361K | Buy |
|
|||||
|
2022
Q1 | $278K | Sell |
|
|||||
|
2021
Q4 | $307K | Sell |
|
|||||
|
2021
Q3 | $2.73M | Buy |
|
|||||
|
2021
Q2 | $2.65M | Sell |
|
|||||
|
2021
Q1 | $1.9M | Buy |
|
|||||
|
2020
Q4 | $1.96M | Sell |
|
|||||
|
2020
Q3 | $1.61M | Sell |
|
|||||
|
2020
Q2 | $3.97M | Buy |
|
|||||
|
2020
Q1 | $3.38M | Buy |
|
|||||
|
2019
Q4 | $4.04M | Sell |
|
|||||
|
2019
Q3 | $1.63M | Buy |
|
|||||
|
2019
Q2 | $1.5M | Buy |
|
|||||
|
2019
Q1 | $921K | Buy |
|
|||||
|
2018
Q4 | $484K | Buy |
|
|||||
|
2018
Q3 | $640K | Buy |
|
|||||
|
2018
Q2 | $46K | Sell |
|
|||||
|
2018
Q1 | $52K | Buy |
|
|||||
|
2017
Q4 | $35K | Buy |
|
|||||
|
2017
Q3 | $32K | Buy |
|
|||||
|
2017
Q2 | $3K | Sell |
|
|||||
|
2017
Q1 | $17K | Sell |
|
|||||
|
2016
Q4 | $125K | Buy |
|
|||||
|
2016
Q3 | $12K | Sell |
|
|||||
|
2016
Q2 | $11K | Buy |
|